Progress in DNA-based heterologous prime-boost immunization strategies for malaria.

Progress in DNA-based heterologous prime-boost immunization strategies for malaria.

An effective vaccine against malaria is urgently required to relieve the immense human suffering and mortality caused by this parasite. A successful subunit vaccine against the liver stage of malaria will require the induction of high levels of protective T cells. Despite success in small animal mod...

Descripció completa

Dades bibliogràfiques
Autors principals:	Moore, A, Hill, A
Format:	Journal article
Idioma:	English
Publicat:	2004

Ítems similars

DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.
per: Hill, A, et al.
Publicat: (2000)

Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
per: Draper, S, et al.
Publicat: (2005)

Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M
per: Venkatraman, N, et al.
Publicat: (2017)

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies.
per: Schneider, J, et al.
Publicat: (1999)

Prime-boost strategies for malaria vaccine development.
per: Dunachie, S, et al.
Publicat: (2003)

Prime-boost vectored malaria vaccines: progress and prospects.
per: Hill, A, et al.
Publicat: (2010)

Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model.
per: Yoshida, K, et al.
Publicat: (2018)

Heterologous priming-boosting immunization of cattle with Mycobacterium tuberculosis 85A induces antigen-specific T-cell responses.
per: Taracha, E, et al.
Publicat: (2003)

Developing a personalized heterologous prime boost vaccination strategy for tumor therapy
per: Ramirez-Valdez, RA
Publicat: (2021)

Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression
per: Ramirez-Valdez, RA, et al.
Publicat: (2023)

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.
per: Vuola, J, et al.
Publicat: (2005)

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria.
per: Keating, S, et al.
Publicat: (2005)

Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin.
per: Vordermeier, H, et al.
Publicat: (2004)

Prime-boost immunization strategies for infectious diseases.
per: Mcshane, H
Publicat: (2002)

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
per: Shaw, RH, et al.
Publicat: (2021)

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis.
per: Gilbert, S, et al.
Publicat: (2006)

Effect of adenovirus dose and prime-boost interval on the immune kinetics of the effector immune response
per: Sridhar, S, et al.
Publicat: (2005)

Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques.
per: Rogers, W, et al.
Publicat: (2001)

Prime-boost immunisation strategies for tuberculosis.
per: Mcshane, H, et al.
Publicat: (2005)

Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas.
per: Rühl, J, et al.
Publicat: (2019)

Vaccination of chimpanzees with a multicomponent DNA-protein prime-boost regimen provides an enhanced recovery following heterologous HCV challenge.
per: Heeney, J, et al.
Publicat: (2001)

Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting
per: Dean, G, et al.
Publicat: (2014)

Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting.
per: Dean, G, et al.
Publicat: (2014)

Long-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol.
per: Bouillet, L, et al.
Publicat: (2011)

Long-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol.
per: Bouillet, L, et al.
Publicat: (2011)

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.
per: Gilbert, S, et al.
Publicat: (2002)

Homologous & heterologous COVID-19 vaccine priming schedules: an analysis of systemic & mucosal immunity
per: Shaw, RYHW
Publicat: (2024)

A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity.
per: Goodman, A, et al.
Publicat: (2011)

Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen in healthy adults in the United Kingdom and Senegal
per: Venkatraman, N, et al.
Publicat: (2018)

Different levels of immunogenicity of two strains of Fowlpox virus as recombinant vaccine vectors eliciting T-cell responses in heterologous prime-boost vaccination strategies.
per: Cottingham, MG, et al.
Publicat: (2006)

Role of transfection in the priming of cytotoxic T-cells by DNA-mediated immunization.
per: Sbai, H, et al.
Publicat: (2002)

Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
per: McAuliffe, J, et al.
Publicat: (2021)

Optimizing HIV-1-specific CD8 + T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors
per: Hopkins, R, et al.
Publicat: (2011)

Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors.
per: Hopkins, R, et al.
Publicat: (2011)

Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations.
per: Kimani, D, et al.
Publicat: (2014)

HETEROLOGOUS PRIME-BOOST VACCINATION WITH ADCH63 AND MVA EXPRESSING MSP1 CAN INDUCE PROTECTIVE EFFICACY AGAINST SPOROZOITE CHALLENGE IN VOLUNTEERS
per: Sheehy, S, et al.
Publicat: (2010)

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
per: Ogwang, C, et al.
Publicat: (2013)

Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses.
per: Reyes-Sandoval, A, et al.
Publicat: (2010)

Safety and immunogenicity of the heterologous prime-boost ebolavirus vaccine regimen CHAD3-EBO Z and MVA-BN (R) FILO in healthy UK adults
per: Rampling, T, et al.
Publicat: (2015)

Erratum: Prime-boost immunization with adenoviral and modified vaccinia virus ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses
per: Reyes-Sandoval, A, et al.
Publicat: (2011)